3,3',5,5'-tetramethylbenzidine has been researched along with Carcinoma, Ehrlich Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filimonov, A; Filimonova, M; Ivanov, S; Kaprin, A; Koryakin, S; Makarchuk, V; Saburov, V; Saburova, A; Sevankaeva, L; Shegay, P; Shevchenko, L; Surinova, V; Yakovleva, N; Yuzhakov, V | 1 |
| Filimonov, AS; Filimonova, MV; Makarchuk, VM; Podosinnikova, TS; Samsonova, AS; Shevchenko, LI | 1 |
2 other study(ies) available for 3,3',5,5'-tetramethylbenzidine and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
The Ability of the Nitric Oxide Synthases Inhibitor T1023 to Selectively Protect the Non-Malignant Tissues.
Topics: Animals; Carcinoma, Ehrlich Tumor; Female; Gamma Rays; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase; Radiation Protection; Radiation-Protective Agents; Radiodermatitis; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental; Thiourea | 2021 |
Comparison of Antitumor Effects of Combined and Separate Treatment with NO Synthase Inhibitor T1023 and PDK1 Inhibitor Dichloroacetate.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Dichloroacetic Acid; Female; Mice; Nitric Oxide Synthase; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Thiourea | 2019 |